https://www.selleckchem.com/products/m3541.html
Of the patients treated with BHC, 52 patients had good prognoses, and one 53-year-old patient with unilateral hematoma died of postoperative acute intracranial bleeding. During the 6-month follow-up period, no relapse occurred in the patients treated with mBHC, whereas 8 (13%) of the patients treated with BHC relapsed. There was a significant difference in the recurrence rate between the 2 groups (P 0.05). In addition, midline recovery, hematoma clearance rate, operation time, and complications were found to be significantly differen
Like
Comment
Share
